Boston Scientific has received CE Mark approval for the Rhythmia Mapping System, a 3-D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to treat a variety of conditions in which the heart beats abnormally. Some of those conditions include atrial flutter, atrial fibrillation and ventricular tachycardia. Boston Scientific is offering the Rhythmia Mapping System with the company's 64 electrode IntellaMap Orion Mapping Catheter, which has also received CE Mark approval. The combination, part of the 2012 Rhythmia Medical acquisition, is designed to provide electrophysiologists with accurate, high-resolution electro-anatomical maps.

With an average satisfaction score of 4.5 out of 5 on security, cloud users feel safe. Non-cloud users though remain at bay-particularly with many questions still looming around the future of cloud computing in healthcare. The KLAS report titled Cloud Computing Perception 2013: The Hybrid Cloud in Healthcare looks at the evolution of the cloud in healthcare, provider concerns, as well as vendor performance.

Scranton Gillette Communications’ sister publications Imaging Technology News and Diagnostic and Interventional Cardiology were honored with American Society of Healthcare Publication Editors (ASHPE) 2013 awards, in recognition of editorial excellence and achievement in the field of healthcare publishing.

eCardio Diagnostics announced the launch of eCardio Verite — a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when directed by a physician.

Zoll Medical said results from the prospective registry and follow-up of Patients Using the Wearable Defibrillator (WEARIT-II) trial will be presented in a late-breaking clinical trial presentation at Heart Rhythm 2013. The session will be presented during the Heart Rhythm Society’s 34th Annual Scientific Sessions, Friday, May 10, 1:30-3 p.m., session number SP22.